Scinai Immunotherapeutics (SCNI) FCF Margin (2024 - 2026)
Scinai Immunotherapeutics (SCNI) posted FCF Margin of 297.14% for Q1 2026, up 63.71% sequentially from 818.72% in Q2 2025, and down 12103.0% YoY from N/an in Q1 2025.
Scinai Immunotherapeutics (SCNI) FCF Margin (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported FCF Margin for 3 years, with the latest figure at 297.14% in Q1 2026.
- Quarterly FCF Margin fell 12103.0% year-over-year to 297.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 273.57% (changed N/A YoY) and the FY2025 annual result came in at 253.45%, up 71114.0% from the prior year.
- FCF Margin grew to 297.14% in Q1 2026 per SCNI's latest filing, from 818.72% in the prior quarter.
- Over five years, FCF Margin peaked at 176.11% in Q1 2025 and troughed at 1210.71% in Q3 2024.
- A 3-year average of 607.33% and a median of 533.98% in 2024 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 12103 bps in 2026, down 12103 bps in 2026.
- Over 3 years, FCF Margin stood at 533.98% in 2024, then sank by 53 bps to 818.72% in 2025, then jumped by 64 bps to 297.14% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 297.14%, 818.72%, and 176.11% for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 70.82% |
| 10 | Scinai Immunotherapeutics | 11.41 Mn | -3.10 Bn | -1.12 Mn | -297.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -297.14% |
| Jun 30, 2025 | -818.72% |
| Mar 31, 2025 | -176.11% |
| Dec 31, 2024 | -533.98% |
| Sep 30, 2024 | -1,210.71% |